Recurrent Malignant Female Reproductive System Neoplasm


biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

Recurrent Malignant Neoplasm of Multiple Primary Sites


Refractory Malignant Neoplasm of Multiple Primary Sites


Refractory Malignant Pharyngeal Neoplasm


Recurrent Malignant Male Reproductive System Neoplasm


Refractory Malignant Male Reproductive System Neoplasm


Recurrent Malignant Soft Tissue Neoplasm


Refractory Malignant Soft Tissue Neoplasm


Recurrent Malignant Thyroid Gland Neoplasm


Refractory Malignant Thyroid Gland Neoplasm


Recurrent Malignant Urinary System Neoplasm


Refractory Malignant Urinary System Neoplasm


Selective Estrogen Receptor Degrader G1T48


Prostate Adenocarcinoma without Neuroendocrine Differentiation


Anti-CD40 Agonist Monoclonal Antibody CDX-1140


Metastatic Gastroesophageal Junction Adenocarcinoma


Unresectable Gastroesophageal Junction Adenocarcinoma


Metastatic malignant neoplasm to viscera


Unresectable Undifferentiated Pleomorphic Sarcoma


Resectable Undifferentiated Pleomorphic Sarcoma


Panobinostat Nanoparticle Formulation MTX110


Anti-LAG-3/PD-L1 Bispecific Antibody FS118


Metastatic Gastrointestinal Stromal Tumor


Locally Advanced Gastrointestinal Stromal Tumor


Unresectable Malignant Gastrointestinal Stromal Tumor


Refractory Metastatic Digestive System Carcinoma


Hematologic Neoplasm with Germline GATA2 Mutation


Anti-PRL-3 Monoclonal Antibody PRL3-zumab


Acyclic Nucleoside Phosphonate Prodrug ABI-1968


Therapeutic Liver Cancer Peptide Vaccine IMA970A


Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


Resectable Pancreatic Ductal Adenocarcinoma


Recurrent Malignant Head and Neck Neoplasm


Metastatic Pancreatic Neuroendocrine Carcinoma


Unresectable Pancreatic Neuroendocrine Carcinoma


CD137L/Epstein-Barr Virus-Targeting Autologous Dendritic Cell Vaccine


Soluble Guanylate Cyclase Stimulator IW-1701


Refractory Hepatosplenic T-Cell Lymphoma


Locally Advanced Skin Squamous Cell Carcinoma


Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


Glucocorticoid Receptor Antagonist CORT125281


Metastatic Unresectable Gastric Adenocarcinoma


Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


Recurrent Gastroesophageal Junction Adenocarcinoma


Locally Advanced Unresectable Soft Tissue Sarcoma


Recurrent Clear Cell Renal Cell Carcinoma


Recurrent Ovarian Mucinous Adenocarcinoma


Recurrent Ovarian Clear Cell Adenocarcinoma


Recurrent Thyroid Gland Papillary Carcinoma


Recurrent Thyroid Gland Follicular Carcinoma


Recurrent Thyroid Gland Medullary Carcinoma


Recurrent Ovarian Transitional Cell Carcinoma


Recurrent Primary Malignant Central Nervous System Neoplasm


Refractory Primary Malignant Central Nervous System Neoplasm


mRNA-based TriMix Melanoma Vaccine ECI-006


Colorectal Cancer Peptide Vaccine PolyPEPI1018


Locally Advanced Squamous Cell Carcinoma


Locally Advanced Sinonasal Squamous Cell Carcinoma


Sinonasal Poorly Differentiated Carcinoma


Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified


Recurrent Chronic Myelomonocytic Leukemia


Advanced Oral Cavity Squamous Cell Carcinoma


Metastatic Oral Cavity Squamous Cell Carcinoma


Advanced Hypopharyngeal Squamous Cell Carcinoma


Advanced Laryngeal Squamous Cell Carcinoma


Refractory Malignant Female Reproductive System Neoplasm


Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01


Refractory Female Reproductive System Carcinoma


Refractory Lung Non-Small Cell Carcinoma


Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Advanced Lung Non-Small Cell Squamous Carcinoma


Metastatic Triple-Negative Breast Carcinoma


Locally Advanced Head and Neck Carcinoma


Complicated skin and soft tissue infection


Olopatadine Hydrochloride Ophthalmic Solution


Vincristine Sulfate Liposome Injection, USP


acute myeloid leukemia/transient myeloproliferative disorder


healthy, no evidence of disease

biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


recurrent extragonadal non-seminomatous germ cell tumor


Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia


childhood high-grade cerebellar astrocytoma


liposome-encapsulated irinotecan hydrochloride PEP02


hormone receptor/growth factor receptor-negative breast cancer


estrogen receptor-negative breast cancer


progesterone receptor-negative breast cancer


adult acute myeloid leukemia with del(5q)


hereditary breast/ovarian cancer - BRCA1


hereditary breast/ovarian cancer - BRCA2


primary central nervous system Hodgkin lymphoma


indium In 111 HER2-specific high-affinity protein ABY-025


stage IVA esthesioneuroblastoma of the paranasal sinus and nasal cavity


stage IVB esthesioneuroblastoma of the paranasal sinus and nasal cavity


stage IVC esthesioneuroblastoma of the paranasal sinus and nasal cavity


stage IVA inverted papilloma of the paranasal sinus and nasal cavity


stage IVB inverted papilloma of the paranasal sinus and nasal cavity


stage IVC inverted papilloma of the paranasal sinus and nasal cavity


stage IVA midline lethal granuloma of the paranasal sinus and nasal cavity


stage IVB midline lethal granuloma of the paranasal sinus and nasal cavity


stage IVC midline lethal granuloma of the paranasal sinus and nasal cavity


stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


stage IV primary peritoneal cavity cancer


recurrent primary peritoneal cavity cancer


Protein Tyrosine Kinase 2 Inhibitor BI 853520


stage IA primary peritoneal cavity cancer


stage IB primary peritoneal cavity cancer


stage IC primary peritoneal cavity cancer


stage IIA primary peritoneal cavity cancer


stage IIB primary peritoneal cavity cancer


stage IIIA primary peritoneal cavity cancer


stage IIIC primary peritoneal cavity cancer


stage IIIB primary peritoneal cavity cancer


stage IVA squamous cell carcinoma of the lip and oral cavity


stage IVB squamous cell carcinoma of the lip and oral cavity


stage IVC squamous cell carcinoma of the lip and oral cavity


stage IVB lymphoepithelioma of the oropharynx


stage IVA lymphoepithelioma of the oropharynx


stage IVC lymphoepithelioma of the oropharynx


metastatic extrahepatic bile duct cancer


Philadelphia chromosome negative adult precursor acute lymphoblastic leukemia


stage A adult primary liver cancer (BCLC)


stage B adult primary liver cancer (BCLC)


Chinese herbal formulation ChangTai Keli


Anti-BCMA Antibody-drug Conjugate AMG 224


PSA/PSMA/PSCA-encoding DNA Plasmid Vaccine PF-06755990


AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992


stage III cutaneous squamous cell carcinoma of the head and neck


stage IV cutaneous squamous cell carcinoma of the head and neck


Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck


Clostridium butyricum CBM 588 Probiotic Strain


Gallium Ga 68-NOTA-anti-HER2 Nanobody VHH1


Anti-CD33/CD3 Bispecific Antibody GEM 333


Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B


Casein Phosphopeptide-Amorphous Calcium Phosphate


Papillomavirus Bivalent (Human) (Recombinant)


acute leukemia of ambiguous lineage in relapse


Unresectable Pleural Malignant Mesothelioma


Recurrent Cutaneous Melanoma of the Extremity


Advanced Cutaneous Melanoma of the Extremity


Locally Advanced Unresectable Renal Cell Carcinoma


Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)


Locally Advanced Unresectable Pancreatic Adenocarcinoma


Recurrent Endometrial Clear Cell Adenocarcinoma


Recurrent Endometrial Mixed Cell Adenocarcinoma


Locally Advanced Unresectable Gastric Adenocarcinoma


Unresectable Lung Non-Small Cell Carcinoma


Metastatic Malignant Neoplasm in the Thoracic Cavity


Locally Advanced Pancreatic Neuroendocrine Carcinoma


Locally Advanced Digestive System Neuroendocrine Carcinoma


Unresectable Digestive System Neuroendocrine Carcinoma


Metastatic Digestive System Neuroendocrine Carcinoma


Refractory Digestive System Neuroendocrine Carcinoma


Refractory Malignant Peripheral Nerve Sheath Tumor


Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma


Metastatic Nasopharyngeal Undifferentiated Carcinoma


Metastatic Lip and Oral Cavity Carcinoma


Metastatic Lung Non-Small Cell Carcinoma


Metastatic Thyroid Gland Follicular Carcinoma


Metastatic Thyroid Gland Papillary Carcinoma


Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


Localized Gastroesophageal Junction Adenocarcinoma


Refractory Aggressive Non-Hodgkin Lymphoma


Locally Advanced Pancreatic Adenocarcinoma


High Risk Chronic Myelomonocytic Leukemia


Locally Advanced Cervical Adenocarcinoma


Locally Advanced Unresectable Cervical Carcinoma


Ginseng/Lingzhi Mushroom/Cordyceps sinensis/Rose Oral Liquid


Recurrent Primary Peritoneal Serous Adenocarcinoma


Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


Recurrent Ovarian Low Grade Serous Adenocarcinoma


Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


Advanced Pancreatic Neuroendocrine Tumor


Metastatic Digestive System Neuroendocrine Neoplasm


Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


Goserelin Acetate Extended-release Microspheres LY01005


Biochemically Recurrent Prostate Carcinoma


Resectable Pancreatic Acinar Cell Carcinoma


Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901


mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902


Hormone Receptor-Positive Breast Carcinoma


Refractory Hormone Receptor-Positive Breast Carcinoma


Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244


Locally Advanced Pancreatic Ductal Adenocarcinoma


Recurrent Endometrial Undifferentiated Carcinoma


Injury of articular cartilage of left knee joint


Injury of articular cartilage of right knee joint


Calcipotriol only product in cutaneous dose form


Fusidic acid only product in oral dose form


Nitroglycerin only product in oromucosal dose form


Hydroxychloroquine only product in oral dose form


Progesterone only product in oral dose form


Albuterol only product in oral dose form


Telmisartan only product in oral dose form


Verapamil only product in oral dose form


PF-ILD-progressive fibrosing interstitial lung disease


Encounter due to hormone replacement therapy


Tadalafil 20 MG Oral Tablet, Includes Pulmonary Hypertension tadalafil 20 MG Oral Tablet


Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)


Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis


Antihemophilic factor (recombinant), glycopegylated-exei


Primary Vitreoretinal Non-Hodgkin Lymphoma


Unresectable Adrenal Gland Pheochromocytoma


Locally Advanced Adrenal Gland Pheochromocytoma


Nimesulide-Hyaluronic Acid Conjugate CA102N


Unresectable Skin Squamous Cell Carcinoma


Monoclonal Gammopathy of Renal Significance


Borderline Resectable Pancreatic Ductal Adenocarcinoma


Colorectal Adenocarcinoma Metastatic in the Liver


Metastatic Lung Non-Small Cell Squamous Carcinoma


Colorectal Carcinoma Metastatic in the Liver


Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder


Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder


Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder


Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder


Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999


Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015


Troxacitabine nucleotide prodrug miv-818


Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents


High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma


Low Grade Anal Intraepithelial Neoplasia


Platinum-Resistant Fallopian Tube Carcinoma


Platinum-Resistant Primary Peritoneal Carcinoma


Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma


Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


Refractory T-Cell Prolymphocytic Leukemia


Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma


Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma


Refractory B-Cell Prolymphocytic Leukemia


Metastatic Bladder Squamous Cell Carcinoma


Metastatic Bladder Plasmacytoid Urothelial Carcinoma


Metastatic Bladder Lipid-Rich Urothelial Carcinoma


Metastatic Sarcomatoid Renal Cell Carcinoma


Metastatic Bladder Large Cell Neuroendocrine Carcinoma


Metastatic Bladder Small Cell Neuroendocrine Carcinoma


Metastatic Prostate Small Cell Neuroendocrine Carcinoma


Metastatic Bladder Micropapillary Urothelial Carcinoma


Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma


Metastatic Bladder Giant Cell Urothelial Carcinoma


Metastatic Malignant Genitourinary System Neoplasm


Recurrent B-Cell Prolymphocytic Leukemia


Advanced Digestive System Neuroendocrine Neoplasm


Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm


Recombinant Bovine Basic Fibroblast Growth Factor


Dihydroorotate Dehydrogenase Inhibitor AG-636


Recurrent Transformed B-Cell Non-Hodgkin Lymphoma


Refractory Transformed B-Cell Non-Hodgkin Lymphoma


Recurrent Transformed Chronic Lymphocytic Leukemia


Refractory Transformed Chronic Lymphocytic Leukemia


Refractory Endometrial Serous Adenocarcinoma


Refractory Endometrial Mixed Cell Adenocarcinoma


Refractory Endometrial Clear Cell Adenocarcinoma


Refractory Adrenal Gland Pheochromocytoma


Sustained-release Mitomycin C Hydrogel Formulation UGN-102


Recurrent Desmoplastic Small Round Cell Tumor


Refractory Desmoplastic Small Round Cell Tumor


Locally Advanced Salivary Gland Carcinoma


Platinum-Resistant Lung Small Cell Carcinoma


Platinum-Sensitive Lung Small Cell Carcinoma


Technetium Tc-99m Anti-HER2 Affibody ABH2


Unresectable Urethral Urothelial Carcinoma


Unresectable Bladder Urothelial Carcinoma


Unresectable Ureter Urothelial Carcinoma


Unresectable Renal Pelvis Urothelial Carcinoma


Metastatic Bladder Sarcomatoid Urothelial Carcinoma


Refractory Digestive System Neuroendocrine Neoplasm


Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma


Recombinant human glutamic acid decarboxylase


Dantrolene Sodium for Injectable Suspension


Classical Hodgkin lymphoma type posttransplant lymphoproliferative disorder


Human papillomavirus negative squamous cell carcinoma


Polyethylene glycol only product in oral dose form


Mixed neuroendocrine-non neuroendocrine neoplasm


Monoclonal B-cell lymphocytosis chronic lymphocytic leukemia-type


Pediatric acute-onset neuropsychiatric syndrome


HHV-8-Associated Multicentric Castleman Disease


Cannabis-induced organic mental disorder


PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1


International Prognostic Index Low Risk Group


International Prognostic Index High Risk Group


Personalized Neoepitope Yeast Vaccine YE-NEO-001


Indocyanine Green-labeled Polymeric Micelles ONM-100


Metastatic Large Cell Neuroendocrine Carcinoma


Metastatic Prostate Neuroendocrine Carcinoma


Metastatic Pancreatic Ductal Adenocarcinoma


Proliferative Glomerulonephritis with Monoclonal IgG Deposits


Fanconi Anemia Complementation Group Gene Mutation


Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H


Advanced Gastroesophageal Junction Adenocarcinoma


Advanced Clear Cell Renal Cell Carcinoma


Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A


Anti-CTLA-4 Monoclonal Antibody REGN4659


OX40L-expressing Oncolytic Adenovirus DNX-2440


Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


TGF-beta Receptor 1 Inhibitor PF-06952229


Anti-CD137 Agonistic Monoclonal Antibody ADG106


Anti-PD-L1/CD137 Bispecific Antibody MCLA-145


Locally Advanced Lung Non-Small Cell Carcinoma


Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191


Platinum-Sensitive Primary Peritoneal Carcinoma


Platinum-Sensitive Fallopian Tube Carcinoma


Locally Advanced Undifferentiated Pleomorphic Sarcoma


Metastatic Clear Cell Sarcoma of Soft Tissue


Metastatic BRCA Hereditary Breast Carcinoma


Hepatocellular Malignant Neoplasm, Not Otherwise Specified


Anti-CD137 Agonistic Monoclonal Antibody CTX-471


Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


Locally Advanced Unresectable Breast Carcinoma


Metastatic Malignant Female Reproductive System Neoplasm


Metastatic Malignant Digestive System Neoplasm


Locally Advanced Unresectable Colorectal Adenocarcinoma


Anti-CD33/CD3 Bispecific Antibody JNJ-67571244


Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


Protein Arginine Methyltransferase 5 Inhibitor PRT543


Intermediate Risk Acute Myeloid Leukemia


HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101


Metastatic Thymus Neuroendocrine Neoplasm


Anti-CTLA-4 Monoclonal Antibody ADU-1604


Pegylated Deoxycytidine Analogue DFP-14927


Glucocorticoid Receptor Antagonist ORIC-101


Refractory Gastroesophageal Junction Adenocarcinoma


Primary Peritoneal Undifferentiated Carcinoma


Primary Peritoneal Transitional Cell Carcinoma


Metastatic Malignant Neoplasm in the Head and Neck


Head and Neck Carcinoma of Unknown Primary


Locally Advanced Ureter Urothelial Carcinoma


Locally Advanced Renal Pelvis Urothelial Carcinoma


Locally Advanced Bladder Urothelial Carcinoma


Locally Advanced Urethral Urothelial Carcinoma


Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01


Unresectable Lung Non-Squamous Non-Small Cell Carcinoma


MET/Src/CSF1R Tyrosine Kinase Inhibitor TPX-0022


Metastatic Thyroid Gland Medullary Carcinoma


Refractory Atypical Teratoid/Rhabdoid Tumor


Locally Advanced Head and Neck Squamous Cell Carcinoma


Locally Advanced Gastroesophageal Junction Adenocarcinoma


Metastatic Papillary Renal Cell Carcinoma


Submicron Particle Paclitaxel Sterile Suspension


Resectable Oropharyngeal Squamous Cell Carcinoma


Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP


MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP


GHR Antisense Oligonucleotide IONIS-GHR-LRx


Unresectable Oropharyngeal Squamous Cell Carcinoma


Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T


Metastatic Paranasal Sinus Squamous Cell Carcinoma


Lignin-derived Polyphenolic Composition with Ammonium Molybdate BP-C2


Locally Advanced Oropharyngeal Squamous Cell Carcinoma


Metastatic Sinonasal Squamous Cell Carcinoma


Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck


New onset diabetes after transplantation


Chronic Pseudomonas aeruginosa infection


Tuberous sclerosis complex associated neuropsychiatric disease


Primary mediastinal large B-cell lymphoma (PMBCL)


Amiodarone Hydrochloride Liquid Injection


Diphenhydramine Hydrochloride Liquid Injection


Doxorubicin Hydrochloride Liquid Injection


Hydromorphone Hydrochloride Liquid Injection


Lidocaine Hydrochloride Liquid Injection


Ropivacaine Hydrochloride Liquid Injection


anorexia nervosa with significantly low body weight


Sexually transmitted infections (excluding HIV and hepatitis)


Leukemia - acute lymphoblastic leukemia (ALL)


Leukemia - chronic lymphocytic leukemia (CLL)


Leukemia - chronic myeloid leukemia (CML)


Fracture of the lower limb (except hip), initial encounter


Heart failure with mid range ejection fraction


Acute exacerbation of idiopathic pulmonary fibrosis


Recurrent Clostridium difficile infection


Endocrine mucin-producing sweat gland carcinoma


Idiopathic macular telangiectasia type 2


Nasopharyngeal Keratinizing Squamous Cell Carcinoma


Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


Organ or tissue replaced by other means, heart assist device


ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005


Advanced Thyroid Gland Medullary Carcinoma


DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151


Locally Advanced Dedifferentiated Liposarcoma


Locally Advanced Malignant Peripheral Nerve Sheath Tumor


Locally Advanced Alveolar Soft Part Sarcoma


Fumarate Hydratase-Deficient Renal Cell Carcinoma


Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma


Advanced Pancreatic Ductal Adenocarcinoma


Invasive Sarcomatoid Urothelial Carcinoma


Unresectable Malignant Peripheral Nerve Sheath Tumor


Soft Tissue Sarcoma of the Trunk and Extremities


Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


Recurrent Ovarian High Grade Serous Adenocarcinoma


Recurrent Fallopian Tube Endometrioid Adenocarcinoma


Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10


Recurrent Endometrial Dedifferentiated Carcinoma


Recurrent Moderate-Severe Chronic Graft Versus Host Disease


Multi-epitope HER2 Peptide Vaccine H2NVAC


Refractory Endometrial Undifferentiated Carcinoma


ER alpha PROTAC Protein Degrader ARV-471


Metastatic Pancreatic Neuroendocrine Neoplasm


Unresectable Clear Cell Renal Cell Carcinoma


Refractory Pancreatic Ductal Adenocarcinoma


Unresectable Lung Neuroendocrine Neoplasm


Unresectable Digestive System Neuroendocrine Neoplasm


Unresectable Pancreatic Neuroendocrine Neoplasm


Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation


Locally Advanced Laryngeal Squamous Cell Carcinoma


Unresectable Triple-Negative Breast Carcinoma


Neoantigen-based Therapeutic Cancer Vaccine GRT-C903


Neoantigen-based Therapeutic Cancer Vaccine GRT-R904


Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1


Refractory Differentiated Thyroid Gland Carcinoma


Refractory Thyroid Gland Papillary Carcinoma


Refractory Thyroid Gland Follicular Carcinoma


Recurrent Differentiated Thyroid Gland Carcinoma


Pooled Mutant KRAS-Targeted Long Peptide Vaccine


Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130


Gallium-based Bone Resorption Inhibitor AP-002


Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459


Locally Advanced Hypopharyngeal Squamous Cell Carcinoma


Locally Recurrent Skin Squamous Cell Carcinoma


Hormone Receptor-Negative Breast Carcinoma


Second Primary Squamous Cell Carcinoma of the Head and Neck


Advanced Undifferentiated Pleomorphic Sarcoma


Refractory Transformed Mycosis Fungoides


Metastatic Primary Malignant Central Nervous System Neoplasm


Locally Advanced Primary Malignant Central Nervous System Neoplasm


Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119


IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000


Refractory Triple-Negative Breast Carcinoma


Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370


Metastatic Nasal Cavity Squamous Cell Carcinoma


Advanced Malignant Female Reproductive System Neoplasm


Locally Advanced Pancreatic Neuroendocrine Tumor


Locally Advanced Neuroendocrine Neoplasm


HPV E6/E7-encoding Arenavirus Vaccine HB-201


Locally Advanced Nasopharyngeal Squamous Cell Carcinoma


Commensal Bacterial Strain Formulation VE800


Other Genetic Syndrome Associated with Congenital Heart Defect


Anti-CD137 Agonistic Monoclonal Antibody AGEN2373


Locally Advanced Thyroid Gland Medullary Carcinoma


Unresectable Differentiated Thyroid Gland Carcinoma


Steroid Resistant Acute Graft Versus Host Disease


Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A


Metastatic HER2-Negative Breast Carcinoma


Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type


Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type


Recurrent HER2-Negative Breast Carcinoma


Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641


Locally Advanced Biliary Tract Carcinoma


Platinum-Resistant Malignant Female Reproductive System Neoplasm


Nanoparticle-based Manganese-containing Contrast Agent SN132D


Recurrent Primary Central Nervous System Neoplasm


Locally Advanced Oral Cavity Squamous Cell Carcinoma


Refractory Thyroid Gland Oncocytic Carcinoma


Microbiome-derived Peptide Vaccine EO2401


Locally Advanced Hepatocellular Carcinoma


Primary Peritoneal Endometrioid Adenocarcinoma


Vaccine product containing only Japanese encephalitis virus antigen (medicinal product)


Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)


Vaccine product containing only Measles morbillivirus antigen (medicinal product)


Vaccine product containing only Mumps orthorubulavirus antigen (medicinal product)


Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)


Vaccine product containing only Clostridium tetani antigen (medicinal product)


Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen conjugated (medicinal product)


Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


Vaccine product containing only Coxiella burnetii antigen (medicinal product)


Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)


Substance with renin-angiotensin system inhibitor mechanism of action (substance)


Vaccine product containing only Human alphaherpesvirus 3 antigen (medicinal product)


Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)


Gene mutations and other alterations NEC


Superparamagnetic Iron Oxide Nanoparticles


Polycystic ovary syndrome of bilateral ovaries


Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer


Voxelotor only product in oral dose form


Vaccine product containing only Influenza virus antigen (medicinal product)


Vaccine product containing only Human papillomavirus antigen (medicinal product)


Vaccine product containing only inactivated whole Rabies lyssavirus antigen


Vaccine product containing only Bacillus anthracis antigen (medicinal product)


Inactivated whole Hepatitis A virus antigen only vaccine product


Acute respiratory distress syndrome due to COVID-19


Adverse reaction to adrenergic receptor antagonist


Vaccine product containing only Yersinia pestis antigen (medicinal product)


Vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product)


Vaccine product containing only Rubella virus antigen (medicinal product)


Pediatric vaccine product containing only Hepatitis A virus antigen (medicinal product)


Vaccine product containing only Bordetella pertussis antigen (medicinal product)


Vaccine product containing only Rotavirus antigen (medicinal product)


Influenza A virus subtype H1N1 antigen only vaccine product


Adverse reaction to arsenic and/or arsenic compound


Vaccine product containing only Hepatitis A and Hepatitis B virus antigens (medicinal product)


stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


adult acute myeloid leukemia with 11q23 (MLL) abnormalities


Salivary Gland Poorly Differentiated Carcinoma


Recombinant Bacterial ACE2 Receptors-like Enzyme


Hepatocellular Macrotrabecular Massive Carcinoma


Allogeneic Autophagosome-enriched Vaccine DPV-001


Liposomal Bcl-2 Antisense Oligonucleotide BP1002


Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006


Fc-engineered Anti-CD40 Agonist Antibody 2141-V11


Aryl Hydrocarbon Receptor Inhibitor IK-175


Anti-EGFR/CD16A Bispecific Antibody AFM24


IRDye800-labeled Heterodimeric Peptide KSP-QRH 919288G


Interleukin-15 Agonist Fusion Protein SHR1501


EphA2-targeting Bicycle Toxin Conjugate BT5528


Cedazuridine/Azacitidine Combination Agent ASTX030


Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318


Oncolytic Type 2 Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor OH2


TGF-beta Receptor 1 Kinase Inhibitor YL-13027


Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217


pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2


Cannabinoid-derived Inhalation Capsule PPP011


Supra-pharmacologic Dexamethasone Sodium Phosphate AVM0703


Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a


HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202


Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01


Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC


Multi-epitope HER2 Peptide Vaccine TPIV100


Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711


Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257


Anti-NaPi2b Antibody-drug Conjugate XMT-1592


Anti-HER2-DM1 Antibody-drug Conjugate GQ1001


DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555


Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002


Non-Neoplastic Chronic Respiratory System Disorder


Locally Advanced Clear Cell Renal Cell Carcinoma


Recurrent Platinum-Resistant Ovarian Carcinoma


Recurrent Platinum-Resistant Fallopian Tube Carcinoma


Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


Recurrent Ovarian Undifferentiated Carcinoma


Recurrent Fallopian Tube Undifferentiated Carcinoma


Recurrent Primary Peritoneal Undifferentiated Carcinoma


Recurrent Fallopian Tube Transitional Cell Carcinoma


Recurrent Primary Peritoneal Transitional Cell Carcinoma


Recurrent Fallopian Tube Clear Cell Adenocarcinoma


Recurrent Primary Peritoneal Adenocarcinoma


Non-Muscle Invasive Bladder Urothelial Carcinoma


Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma


Upper Alveolar Ridge Squamous Cell Carcinoma


Lower Alveolar Ridge Squamous Cell Carcinoma


Locally Advanced Oropharyngeal Carcinoma


Metastatic Endometrial Endometrioid Adenocarcinoma


Metastatic Thyroid Gland Anaplastic Carcinoma


Advanced Ovarian Endometrioid Adenocarcinoma


Advanced Ovarian Clear Cell Adenocarcinoma


Locally Advanced Thyroid Gland Carcinoma


Unresectable Primary Peritoneal Carcinoma


Recurrent Triple-Negative Breast Carcinoma


Refractory Ovarian Serous Adenocarcinoma


Metastatic Fallopian Tube High Grade Serous Adenocarcinoma


Unresectable Fallopian Tube High Grade Serous Adenocarcinoma


Metastatic Primary Peritoneal Serous Adenocarcinoma


Unresectable Primary Peritoneal Serous Adenocarcinoma


Refractory Primary Peritoneal Serous Adenocarcinoma


Human Papillomavirus-Related Mucosal Head and Neck Squamous Cell Carcinoma


Unresectable Primary Central Chondrosarcoma


Metastatic Primary Central Chondrosarcoma


Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma


Asymptomatic COVID-19 Infection Laboratory-Confirmed


Symptomatic COVID-19 Infection Laboratory-Confirmed


COVID-19-Associated Acute Respiratory Distress Syndrome


Metastatic Chromophobe Renal Cell Carcinoma


Advanced Sarcomatoid Renal Cell Carcinoma


Metastatic Renal Cell Carcinoma, Not Otherwise Specified


Advanced Esophageal Squamous Cell Carcinoma


Unresectable Esophageal Squamous Cell Carcinoma


Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm


Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm


Locally Advanced Papillary Renal Cell Carcinoma


Locally Advanced Sarcomatoid Renal Cell Carcinoma


Locally Advanced Esophageal Adenocarcinoma


Unresectable Pancreatic Ductal Adenocarcinoma


Advanced Renal Pelvis Urothelial Carcinoma


Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


Locally Advanced Esophageal Squamous Cell Carcinoma


Severe Acute Respiratory Distress Syndrome


Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


Recurrent Acute Leukemia of Ambiguous Lineage


Refractory Acute Leukemia of Ambiguous Lineage


Unresectable Oral Cavity Squamous Cell Carcinoma


Unresectable Laryngeal Squamous Cell Carcinoma


Unresectable Hypopharyngeal Squamous Cell Carcinoma


Unresectable Paranasal Sinus Squamous Cell Carcinoma


Unresectable Salivary Gland Squamous Cell Carcinoma


Refractory Indolent Non-Hodgkin Lymphoma


Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC


Unresectable Anal Squamous Cell Carcinoma


Microsatellite Stable Colorectal Carcinoma


Refractory Microsatellite Stable Colorectal Carcinoma


Topotecan Sustained-release Episcleral Plaque


Refractory Acute Undifferentiated Leukemia


Extended Release Metformin Hydrochloride


Metastatic Pharyngeal Squamous Cell Carcinoma


Recurrent Pharyngeal Squamous Cell Carcinoma


Locally Advanced Intrahepatic Cholangiocarcinoma


Metastatic Differentiated Thyroid Gland Carcinoma


Advanced Differentiated Thyroid Gland Carcinoma


Advanced Cervical Adenosquamous Carcinoma


Metastatic Poorly Differentiated Thyroid Gland Carcinoma


Gallium Ga 68-NOTA-anti-MMR-VHH2 Nanobody


Locally Advanced Adrenal Cortical Carcinoma


Locally Advanced Cervical Squamous Cell Carcinoma


Resectable Pancreatic Adenosquamous Carcinoma


Metastatic Thyroid Gland Oncocytic Carcinoma


Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


Anti-SARS-CoV-2 equine immunoglobulin fragments


Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


Locally Advanced Hypopharyngeal Carcinoma


Injection, sacituzumab govitecan-hziy, 2.5 mg


Arrhythmogenic left ventricular cardiomyopathy


Influenza A virus subtype H5N1 antigen only vaccine product


Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product


Fluoroestradiol f 18, diagnostic, 1 millicurie


Clonal Cytopenia of Undetermined Significance


Cancer with a high tumour mutational burden


Clostridioides difficile infection recurrence


Hormone receptor negative HER2 positive breast cancer


Instiladrin (tradename for Nadofaragene Firadenovec)


Hydroxyprogesterone Caproate Liquid Injection


Advanced Triple-Negative Breast Carcinoma


Locally Advanced Triple-Negative Breast Carcinoma


Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102


Attenuated Measles Virus Encoding SCD Transgene TMV-018


Anti-5T4 Antibody-drug Conjugate SYD1875


Adenosine A2A Receptor Antagonist CS3005


Anti-CCR7 Antibody-drug Conjugate JBH492


FAP/4-1BB-targeting Fusion Protein RO7122290


Locally Advanced Thyroid Gland Oncocytic Carcinoma


Anti-BTN3A Agonistic Monoclonal Antibody ICT01


Metastatic Primary Malignant Brain Neoplasm


Technetium Tc-99m Anti-HER2 Affibody HPArk2


ESR1 Peptides/GM-CSF/Montanide ISA Vaccine


Anti-survivin T-cell Receptor/Anti-CD3 Bispecific Therapeutic ABBV-184


Abiraterone Amorphous Solid Dispersion Formulation DST-2970


Anti-MUC16/CD28 Bispecific Antibody REGN5668


RNR Subunits Interaction Inhibitor TAS1553


STING Agonist-containing PTGFRN-expressing Exosomes CDK002


Mendelian susceptibility to mycobacterial disease


Locally Recurrent Head and Neck Squamous Cell Carcinoma


Non-Functioning Lung Neuroendocrine Tumor


Locally Advanced Lung Neuroendocrine Neoplasm


Locally Advanced Unresectable Primary Central Chondrosarcoma


HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2


Interleukin-2/Interleukin-15 Receptor Agonist NL-201


PD-1 Targeted IL-15 Mutein Fusion Protein PF-07209960


Anti-OX40 Agonist Monoclonal Antibody YH-002


Erythrocyte Pyruvate Kinase Activator FT-4202


Microbiome-derived Peptide Vaccine EO2463


Myeloid Cell Leukemia 1 Inhibitor PRT1419


PARP/Microtubule Polymerization Inhibitor AMXI-5001


Anti-PD-L1/CD27 Bispecific Antibody CDX-527


Anti-MUC1/EGFR Bispecific Antibody Drug Conjugate M1231


Metastatic Nasopharyngeal Non-Keratinizing Carcinoma


Listeria monocytogenes-LLO-Prostate Cancer Neoantigens Vaccine ADXS-504


Immune Checkpoint Inhibitor-related Myocarditis


Sjogren syndrome with other organ involvement


Piflufolastat F 18 Intravenous Solution [PYLARIFY]


bamlanivimab and etesevimab drug combination


hematopoietic stem cell transplantation-associated thrombotic microangiopathy


Necrosis of brain caused by ionizing radiation


Vitamin D deficiency due to chronic kidney disease


Poisoning caused by Clostridium botulinum toxin


Blood oxygen concentration below reference range (finding)


Adverse reaction caused by dapagliflozin


Prostatitis category III (National Institute of Health classification)


Isocitrate Dehydrogenase 1 Inhibitor [EPC]


Mineralocorticoid Receptor Antagonist [EPC]


Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential


Therapeutic Autologous Platelet-rich Plasma


Anti-interleukin-1 Beta Monoclonal Antibody FL-101


Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody/CD40L/4-1BBL RP3


HPV positive rectal squamous cell carcinoma


Heart failure with midrange ejection fraction


Advanced Cervical Squamous Cell Carcinoma


CD3-activating CD19 Bi-specific Antibody A-319


Metastatic Malignant Nongerminomatous Germ Cell Tumor


Metastatic Microsatellite Stable Colon Carcinoma


Locally Advanced Digestive System Neuroendocrine Neoplasm


Anti-FOXP3 Antisense Oligonucleotide AZD8701


Anti-TREM1 Agonistic Monoclonal Antibody PY159


HPV L1 Virus-like Particles Vaccine NBP615


Anti-GITR AgonisticMonoclonal Antibody REGN6569


Recombinant HSA/G-CSF Fusion Protein MW05


Locally Advanced HER2-Negative Breast Carcinoma


Triple-Class Refractory Multiple Myeloma


Cancer Cell Metabolism Modulator OMT-111


Anti-PSMA Antibody-drug Conjugate ARX517


Anti-OX40/CD137 Bispecific Antibody FS120


PD-1-positive B-cell Peptide Antigen/MVF IMU-201/Montanide Vaccine


A2A/A2B Adenosine Receptor Antagonist INCB106385


Anti-EGFR/c-Met Bispecific Antibody CKD-702


Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma


Refractory Aggressive B-Cell Non-Hodgkin Lymphoma


Anti-CD19/CD3 Bispecific Antibody GNR-084


Nanoparticle SN-38-encapsulated Micelle Formulation SNB-101


Recurrent Fallopian Tube Mucinous Adenocarcinoma


Recurrent Ovarian Seromucinous Carcinoma


Refractory Fallopian Tube Mucinous Adenocarcinoma


Refractory Ovarian Seromucinous Carcinoma


Refractory Fallopian Tube Endometrioid Adenocarcinoma


Refractory Fallopian Tube Transitional Cell Carcinoma


Refractory Fallopian Tube Undifferentiated Carcinoma


Refractory Fallopian Tube High Grade Serous Adenocarcinoma


Refractory Ovarian High Grade Serous Adenocarcinoma


Refractory Low Grade Fallopian Tube Serous Adenocarcinoma


Refractory Ovarian Low Grade Serous Adenocarcinoma


Refractory Ovarian Clear Cell Adenocarcinoma


Refractory Ovarian Mucinous Adenocarcinoma


Refractory Ovarian Transitional Cell Carcinoma


Refractory Ovarian Undifferentiated Carcinoma


Refractory Primary Peritoneal Clear Cell Adenocarcinoma


Refractory Primary Peritoneal Endometrioid Adenocarcinoma


Refractory Primary Peritoneal High Grade Serous Adenocarcinoma


Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma


Refractory Primary Peritoneal Transitional Cell Carcinoma


Refractory Primary Peritoneal Undifferentiated Carcinoma


Platinum-Refractory Malignant Female Reproductive System Neoplasm


Platinum-Refractory Fallopian Tube Carcinoma


Platinum-Refractory Primary Peritoneal Carcinoma


Anti-STn Antibody-drug Conjugate SGN-STNV


Recurrent Diffuse Midline Glioma, H3 K27M-Mutant


Personalized Peptides-loaded Autologous Dendritic Cell Vaccine


R. glutinosa/P. suffruticosa/S. chinensis/A. cochinchinensis/P. armeniaca/S. baicalensis/S. sessilifolia Herbal Supplement HL301


Autologous Ovarian Cancer-specific Antigens-pulsed Dendritic Cells Cellgram-DC


ADAM9-targeting Antibody-drug Conjugate IMGC936


Epstein-Barr Virus gp350-ferritin Nanoparticle Vaccine with Saponin-based Adjuvant


Anti-claudin18.2 Monoclonal Antibody ASKB589


Engineered Red Blood Cells Expressing HPV16 E7/4-1BBL/IL-12 RTX-321


Anti-BCMA/Alpha-amanitin Antibody-drug Conjugate HDP-101


Metastatic Digestive System Neuroendocrine Tumor G2


Unresectable Digestive System Neuroendocrine Tumor G1


Metastatic Platinum-Resistant Ovarian Carcinoma


mRNA-encoded Anti-Claudin18.2 Monoclonal Antibody BNT141


Anti-CD137/PD-L1 Bispecific Antibody FS222


Anti-PD-L1/Anti-4-1BB Bispecific Antibody ABL503


Therapeutic Prostate Cancer Peptide Vaccine TENDU


Anti-PD-L1 Monoclonal Antibody/VEGFR1 Fusion Protein HB0025


DDX Nanoparticles-encapsulated IL-12 and RIG-I Activating DNA Plasmid EG-70


FR Alpha/TRPV6 Bispecific Ligand Drug Conjugate CBP-1008


Refractory Thyroid Gland Medullary Carcinoma


Anti-EGFRvIII/CD3/PD-L1/4-1BB Tetra-specific Antibody GNC-039


Endometrial Low Grade Endometrioid Adenocarcinoma


EGFR/CD3-targeting T-cell Engaging Molecule TAK-186


Muscle Invasive Bladder Urothelial Carcinoma


Localized Muscle Invasive Bladder Urothelial Carcinoma


CD122-selective IL-2/Anti-CD25 Antibody-like Fusion Protein ANV419


Nanoparticles Encapsulating TLR7 Agonist 1v270 MBS8


Anti-KLK2/CD3 Bispecific Antibody JNJ-78278343


Anti-CD137 Agonistic Monoclonal Antibody EU101


Anti-EGFRvIII/CD3 Bispecific Antibody hEGFRvIII:CD3 bi-scFv


Cervical Squamous Cell Carcinoma, Not Otherwise Specified


pH Low Insertion Peptide-exatecan Conjugate CBX-12


Unresectable Thymus Neuroendocrine Neoplasm


Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck


Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707


Metastatic HER2-Positive Breast Carcinoma


Human Papillomavirus-Related Vaginal Adenocarcinoma


Refractory Clear Cell Sarcoma of Soft Tissue


Recurrent Clear Cell Sarcoma of Soft Tissue


Anti-PD-1/Anti-TIM-3 Bispecific Antibody AZD7789


PSMA/FRa Bispecific Peptide-drug Conjugate CBP-1018


Anti-LAG-3/Anti-PD-L1 Bispecific Antibody IBI323


Advanced Vaginal Adenosquamous Carcinoma


Recombinant Human Papillomavirus 14-valent Vaccine SCT1000


Advanced Vaginal Squamous Cell Carcinoma


Early Stage Triple-Negative Breast Carcinoma


Anti-TMEFF2/Anti-CD3 Bispecific Antibody JNJ-70218902


Anti-BCMA/Anti-CD3 Bispecific Antibody WVT078


Locally Advanced HER2-Positive Breast Carcinoma


Engineered Toxin Body Targeting PD-L1 MT-6402


Personalized Cancer Neoantigen Vaccine MVA-PEV


Personalized Cancer Neoantigen Vaccine GAd-PEV


Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified


Refractory Fallopian Tube Clear Cell Adenocarcinoma


Immunoglobulin G1-lambda2, anti-[Homo sapiens IL33 (interleukin 33, DVS27, NF-HEV, IL1F11)], monoclonal antibody; gamma1 heavy chain (1-456) [VH (Homo sapiens IGHV3-23*01 (93.9%) -(IGHD) -IGHJ4*01 (85.7%) L123>M (121)) CDR-IMGT [8.8.19] (26-33.51-58.97-1


Anti-CD47/Anti-PD-L1 Bispecific Antibody PF-07257876


Anti-EGFR Antibody-drug Conjugate ABBV-637


Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F capsular polysaccharide conjugated antigens only vaccine product


complication following peripheral nerve block


coronavirus covid-19 infection variant omicron


nirmatrelvir and ritonavir drug combination


cabotegravir extended-release injectable suspension


Acute kidney injury following administration of contrast media


choroidal neovascularization (physical finding)


C-Terminal Telopeptide Type 1 Collagen, human


Epidermal growth factor receptor inhibitor


Neonatal hypoxic and ischemic brain injury


Extramedullary Disease in Plasma Cell Myeloma


Listerine Cool Mint Zero Alcohol Mouthwash


Metabolic associated fatty liver disease


Anti-HLA-G/CD3 Bispecific Antibody JNJ-78306358


SARS-CoV-2 Spike Protein DNA Vaccine VAX-001


Anti-SARS-CoV-2 Hyperimmune Globulin CSL760


ChAdOx1-vectored COVID-19 Variant Vaccine AZD2816


Anti-PD-L1/TGF-beta Bispecific Antibody Y101D


Anti-CD137 Agonistic Monoclonal Antibody YH004


Anti-claudin 18.2 Antibody-drug Conjugate CPO102


Anti-CD47/Anti-PD-L1 Bispecific Antibody 6MW3211


Bacterial Type III Secretion-based Agent T3P-Y058-739


Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody MVR-C5252


ER Alpha-targeting Chimeric Protein Degrader AC682


Anti-B7-H4/Anti-CD3 Bispecific Antibody PF-07260437


Anti-CD47/Anti-HER2 Bispecific Antibody IMM2902


GM-CSF-secreting MVX-2-loaded Capsules/Autologous Irradiated Tumor Cell Vaccine MVX-ONCO-2


Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HLX301


Anti-PD-1/Anti-CD3 Bispecific Antibody ONO-4685


SARS-CoV-2 Spike Protein Plasmid DNA Vaccine CORVax


Lyophilized Inactivated Group A Streptococcus TARA-002


Anti-PD-L1/Anti-LAG-3 Bispecific Antibody ABL501


Pegylated CD25/CD122-selective Interleukin-2 Mutein STK-012


CD137/Nectin-4 Bispecific-targeting Agent BT7480


Anti-B7-H4/ TOP1i Antibody-drug Conjugate AZD8205


NKp46/CD16-based CD123-targeted NK Cell Engager SAR443579


Anti-CD79b Antibody-drug Conjugate SHR-A1912


Anti-CLDN6 Antibody-drug Conjugate TORL-1-23


Anti-PSMA/CD3 Bispecific Antibody REGN4336


Anti-FLT3/CD3 Bispecific Antibody CLN-049


Lipid Nanoparticle-encapsulated EBV mRNA Vaccine mRNA-1189


Anti-CD20 Antibody-drug Conjugate MRG001


Leuprolide Acetate for Injectable Suspension TOL2506


Anti-CD20/anti-CD3 Bispecific Antibody CM355


Anti-CD117/Amanitin Antibody-drug Conjugate MGTA-117


Anti-interleukin-1 Beta Monoclonal Antibody AK114


Anti-PD-1/Anti-TGF-beta Bifunctional Fusion Protein TQB2868


Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1


Anti-CD200R1 Monoclonal Antibody 23ME-00610


Bifunctional TGF-beta Antagonist/IL-15 Protein Complex HCW9218


Folate-receptor Alpha-targeting Ultrasmall Silica Nanoparticle-drug Conjugate ELU001


Oncolytic HSV-1 Expressing IL-12 and IL-15/IL-15-receptor Alpha VG2025


Recurrent Astrocytoma, IDH-Mutant, Grade 4


Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


Ficus septica Leaf-based Supplement FADA


Recurrent HER2-Positive Breast Carcinoma


Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


Recurrent Indolent B-Cell Non-Hodgkin Lymphoma


Refractory Indolent B-Cell Non-Hodgkin Lymphoma


Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A


Recurrent Hormone Receptor-Positive Breast Carcinoma


Hematologic Neoplasm with Germline SAMD9 Mutation


Hematologic Neoplasm with Germline SAMD9L Mutation


Locally Advanced Nasal Cavity Squamous Cell Carcinoma


Locally Advanced Paranasal Sinus Squamous Cell Carcinoma


Metastatic Hormone Receptor-Positive Breast Carcinoma


Metastatic Triple-Negative Breast Inflammatory Carcinoma


Unresectable Ovarian High Grade Serous Adenocarcinoma


Unresectable Ovarian Endometrioid Adenocarcinoma


Unresectable Fallopian Tube Endometrioid Adenocarcinoma


Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma


Unresectable Primary Peritoneal Endometrioid Adenocarcinoma


Unresectable HER2-Positive Breast Carcinoma


Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation


Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation


Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


Anti-Claudin18.2 Monoclonal Antibody TORL-2-307-MAB


Growth hormone insensitivity syndrome (GHIS)


Chronic primary epigastric pain syndrome


Uveitis due to juvenile idiopathic arthritis


Plasma, high titer covid-19 convalescent, each unit


Accelerated Phase Myeloproliferative Neoplasm


Anti-PD-L1/Anti-OX40 Bispecific Antibody EMB-09


Adenosine A2A Receptor Antagonist ILB2109


Anti-Claudin18.2/Anti-CD3 Bispecific Antibody QLS31905


Mutant-selective EGFR Inhibitor BDTX-1535


Polymeric Nanoparticle-conjugated Camptothecin DAN-222


Anti-B7-H3 Antibody-drug Conjugate HS-20093


mRNA-encoded Anti-CD3/Anti-CLDN6 Bispecific Antibody BNT142


Cytotoxic Agent-LAT1 Substrate QBS10072S


Anti-OX40 Agonist Monoclonal Antibody HFB301001


EGFR Mutant-selective Inhibitor BPI-361175


Personalized Liposomal Neoantigen-based Peptide Vaccine EVX-01


Anti-TROP2 Antibody-drug Conjugate BIO-106


Anti-TROP2 Antibody-drug Conjugate BL-M02D1


Mutant-selective PI3K-alpha H1047R Inhibitor LOXO-783


Commensal Bacterial Strain Formulation BMC128


Anti-c-Met Antibody-drug Conjugate BYON3521


Anti-EGFR/c-MET/c-MET Trispecific Antibody GB263T


Mutant-selective PI3K-alpha Inhibitor BPI-21668


Personalized Neoantigen Vaccine NECVAX NEO1


IL-2 Superkine-Recombinant Human Albumin Fusion Protein MDNA11


Oncolytic HSV-1 Expressing Anti-PD-1 scFv-Fc/TGFbRII Decoy/IL-12 STI-1386


Octreotide Sustained-release Formulation Debio 4126


WT1-targeted IL-2-based Fusion Protein CUE-102


Anti-PD-1/Anti-TIM-3 Bispecific Antibody LB1410


Anti-B7-H6/Anti-CD3 Bispecific Antibody BI 765049


Anti-EGFR/Anti-CD3 Bispecific Probody AMG 651


Anti-CD39 Antibody/TGF-beta RII Ectodomain Fusion Protein ES014


Oncolytic Type 2 Herpes Simplex Virus Expressing Anti-PD-L1/CD3 Bispecific Antibody BS-006


Anti-CD20 Antibody-drug Conjugate TRS005


Anti-CDH17/Anti-CD3 Bispecific Antibody ARB202


Cathepsin-targeted Fluorescent Imaging Probe VGT-309


Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HB0036


Anti-MICA/MICB Monoclonal Antibody CLN-619


MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000


Anti-ENPP3/Anti-CD3 Bispecific Antibody XmAb819


Anti-TROP-2 Antibody-drug Conjugate DB-1305


Anti-CD79b/CD20/CD3 Trispecific Antibody JNJ-80948543


Anti-B7-H3 Antibody-drug Conjugate YL201


Anti-CD20/CD37 Monoclonal Antibody Combination PSB202


Oral Irinotecan Hydrochloride Formulation VAL-413


Anti-Claudin-18.2 Monoclonal Antibody SPX-101


PSMA-targeting T-cell Redirecting Agent JNJ-80038114


Viral Vector-based Cancer Vaccine VAC85135


Anti-HLA-A2-MAGE-A4/Anti-CD3 Bispecific Antibody RG6129


Anti-CTLA-4 Monoclonal Antibody SHR-8068


Anti-Claudin18.2 Antibody-drug Conjugate IBI343


Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363


Anti-CEACAM5 Antibody-drug Conjugate M9140


Anti-HER2 Antibody-drug Conjugate BL-M07D1


Anti-DLL3/CD3 Bispecific Antibody QLS31904


Paclitaxel-conjugated CXCR4 Peptide Antagonist MB1707


Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary


Paclitaxel-loaded Tumor Penetrating Microparticles


Unresectable Hormone Receptor-Positive Breast Carcinoma


Unresectable HER2-Negative Breast Carcinoma


Refractory Childhood Soft Tissue Sarcoma


Locally Advanced Digestive System Neuroendocrine Tumor G1


Unresectable Digestive System Neuroendocrine Tumor G2


Locally Advanced Unresectable HER2-Negative Breast Carcinoma


Locally Advanced Hormone Receptor-Positive Breast Carcinoma


Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma


Locally Advanced Unresectable Triple-Negative Breast Carcinoma


Locally Advanced Unresectable Cholangiocarcinoma


Locally Advanced Unresectable Gallbladder Carcinoma


Refractory Childhood Acute Myeloid Leukemia


Fluorine F 18 Para-chloro-2-fluoroethyl-etomidate


Locally Advanced Thyroid Gland Anaplastic Carcinoma


Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder


Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder


Metastatic Uterine Corpus Leiomyosarcoma


Locally Advanced Uterine Corpus Leiomyosarcoma


Unresectable Uterine Corpus Leiomyosarcoma


CMV pp65 Peptide-loaded Alpha-type-1 Polarized Dendritic Cell Vaccine


Estrogen Receptor-Positive Breast Carcinoma


Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


Recurrent ALK-Positive Large B-Cell Lymphoma


Refractory ALK-Positive Large B-Cell Lymphoma


Childhood Diffuse Intrinsic Pontine Glioma


Childhood Hematopoietic and Lymphoid Cell Neoplasm


Blood glucose below reference range (finding)


Autologous DNP-conjugated tumour vaccine


ESKETAMINE HYDROCHLORIDE 28 mg in 0.2 mL NASAL SOLUTION [Spravato]


Pneumonia due to other Gram-negative bacteria


Dupuytren's contracture (physical finding)


Metastatic papillary renal cell carcinoma (disorder)


Metastatic chromophobe renal cell carcinoma (disorder)


Open spinal dysraphism with a myelomeningocele


BUPivacaine 0.25% preservative-free injectable solution


BUPivacaine 0.5% preservative-free injectable solution


IRAK4/Ikaros/Aiolos Protein Degrader KT-413


Aminolevulinic Acid Intravenous Formulation SONALA-001


Anti-C5 Monoclonal Antibody/Complement Factor H 1-5 Domain Fusion Protein KP104


Acetylglucosaminyltransferase V Inhibitor PhOx430


Locally Advanced Unresectable Uveal Melanoma


Anti-HER2 Antibody-drug Conjugate JSKN003


Locally Recurrent Lung Non-Small Cell Carcinoma


Tri-specific NK Cell Engager Therapeutic Agent CC-92328


Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 JCXH-211


Anti-SIRPa Monoclonal Antibody BI 770371


Advanced Ovarian High Grade Serous Adenocarcinoma


Anti-folate Receptor Alpha Antibody-drug Conjugate AMT-151


CARD11-BCL10-MALT1 Complex Inhibitor XL114


Anti-CD137/Anti-FAP Bispecific Antibody BI 765179


Anti-PSMA/CD3 Protease-activated T-cell Engager JANX007


Recurrent Non-Muscle Invasive Bladder Carcinoma


Unresectable Pancreatic Neuroendocrine Tumor


Anti-GD2 scFv/Anti-DOTA scFv Fusion Protein GD2-SADA


Recurrent Astrocytoma, IDH-Mutant, Grade 3


Renal Cell Carcinoma, Not Otherwise Specified


Intracardiac Thrombus Related to COVID-19


Left Ventricular Thrombus Related to COVID-19


Cerebral Venous Thrombosis Related to COVID-19


Coronary Artery Aneurysm Related to COVID-19


Deep Venous Thrombosis Related to COVID-19


Disseminated Intravascular Coagulation Related to COVID-19


Pericardial Effusion Related to COVID-19


Microvascular Thrombosis Related to COVID-19


Anti-CLDN18.2 Monoclonal Antibody ZL-1211


NFE2L2/KEAP1/CUL3 Mutant-targeting Agent MGY825


Anti-CD19-Glucosteroid Receptor Modulator ADC ABBV-31


Anti-LILRB2 Monoclonal Antibody BMS-986406


Recurrent Extrapulmonary Neuroendocrine Carcinoma


Unresectable Extrapulmonary Neuroendocrine Carcinoma


Metastatic Extrapulmonary Neuroendocrine Carcinoma


Advanced Extrapulmonary Neuroendocrine Carcinoma


EGFR Mutant-selective Inhibitor QLH11811


IL-2/Anti-IL-2 Antibody Conjugate SLC-3010


Anti-CEA/Anti-4-1BB Bispecific Antibody BGB-B167


Hypochlorous Acid-containing Wound Spray APR-TD011


Anti-TCR Vb6/Vb10/IL-2 Antibody Fusion Protein STAR0602


Anti-c-Met/EGFR/VEGF Trispecific Antibody TAVO412


Refractory Rare Malignant Solid Neoplasm


Microbiome-derived Peptide Vaccine EO4010


Neoantigen Heat Shock Protein Vaccine rHSC-DIPGVax


Recurrent Atypical Chronic Myeloid Leukemia


Recurrent Juvenile Myelomonocytic Leukemia


Anti-TIGIT/Anti-PVRIG Bispecific Antibody PM1009


Locally Recurrent Oral Cavity Squamous Cell Carcinoma


Locally Recurrent Oropharyngeal Squamous Cell Carcinoma


Locally Recurrent Laryngeal Squamous Cell Carcinoma


Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma


HM15211 (LONG-ACTING GLP-1/GIP/GLUCAGON TRIPLE AGONIST)


EGFR Tri-specific Natural Killer Cell Engager DF9001


Porphobilinogen deaminase, human recombinant


Japanese Encephalitis Vaccine, Inactivated, Adsorbed


Autosomal dominant hypocalcemia type 1 (ADH1)


Modified Vitamin D Binding Protein Macrophage Activator


Greasy skin due to excessive secretion of sebum


tacrolimus 1 MG Oral Capsule includes BX Rating


tacrolimus 5 MG Oral Capsule includes BX Rating


Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements


Hereditary Transthyretin Amyloidosis with Polyneuropathy


Anti-CTLA-4 Monoclonal Antibody-IL-15/IL-15Ra Fusion Protein JK08


Anti-PD-L1/Anti-VEGF Bispecific Antibody Fusion Protein B1962


Anti-CLDN18.2 Heavy Chain Antibody Fc Fusion Protein DR30303


Anti-DLL3/CD3/CD137 Trispecific Antibody ALPS12


Anti-PD-1/LAG-3 Bispecific Antibody AK129


Long-acting Recombinant Erwinia asparaginase JZP-341


Lenalidomide Prolonged-release Formulation NEX-20A


Ultra-micronized Palmitoyl Ethylamine (PEA) FSD-201


Anti-HER2 Antibody-drug Conjugate IBI354


Microbiome-derived Peptide Vaccine EO2040


Anti-BCMA/GPRC5D/CD3 Trispecific Antibody JNJ-79635322


Anti-Progranulin Monoclonal Antibody AG01


Anti-B7-H4/Anti-4-1BB Bispecific Antibody CLN-418


Anti-EGFR/anti-CD3 Tumor Protease-activated T-cell Engager JANX008


Pan-mutant-selective PI3K-alpha Inhibitor RLY-5836


Anti-FAP Antibody-drug Conjugate OMTX705


Anti-CD33/CD123/CD70 DARPin CD3 Engager MP0533


Anti-PD-1/Anti-ILT4 Bispecific Antibody CDX-585


Anti-FRa Antibody-drug Conjugate AZD5335


Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978


Anti-EpCAM/Anti-CD3 Bispecific Antibody BA3182


Anti-CD44v9 Antibody-drug Conjugate AMT-116


Anti-nectin-4 Antibody-drug Conjugate SHR-A2102


Integrin AlphaVbeta3-targeted Small Molecule-drug Conjugate VIP236


Anti-CLDN6/CD3 Bispecific Antibody SAIL66


Recombinant Newcastle Disease Virus-encoding Interleukin-12 V938


Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002


Recombinant Albumin-binding IL-12 SON-1010


Mutated Human Nerve Growth Factor CHF6467


Anti-SIRPalpha Monoclonal Antibody BYON4228


Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102


Anti-CD3/CD38 Bispecific Monoclonal Antibody IGM-2644


Anti-PD-L1 Antibody/IL-15 Fusion Protein IGM-7354


Heat Shock Factor 1 Pathway Inhibitor NXP800


Antibody receptor-Trap Fusion Protein IMM2520


Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate DB-1310


Anti-PD-L1/4-1BB Bispecific Antibody QLF31907


Anti-4-1BB/5T4 Bispecific Antibody ALG.APV-527


Anti-CD123/CD16A Bispecific Antibody AFM28


Anti-CD20/Anti-CD3 Bispecific Antibody MBS303


Anti-PD-L1/Anti-CD47 Bispecific Monoclonal Antibody LB101


FRa/TRPV6 Bispecific Ligand-drug Conjugate CBP-1019


IL-12/Anti-CTLA-4 Monoclonal Antibody-expressing Oncolytic Viral Vector TG6050


NKp46/CD16/CD20/IL-2-variant-specific NK Cell Engager IPH6501


NKp46/CD16-based BCMA-targeted NK Cell Engager SAR445514


Anti-EGFR Antibody-drug Conjugate CPO301


Allogeneic EBV-transformed B-lymphoblastoid Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine KSD-101


Anti-CEA/Anti-CD3 Bispecific Antibody BA1202


Anti-GARP/PD-L1 Bispecific Antibody BPB-101


Anti-latent TGF-beta1 Monoclonal Antibody RG6440


Anti-PD-1 Antibody AI-025/Anti-CTLA-4 Antibody ONC-392 Combination Formulation AI-061


Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102


Anti-DLL3/DLL3/CD3 Trispecific Antibody ZG006


PSMA-targeting Fluorescent Imaging Agent IS-002


Anti-PD-1/Anti-TGFbRII Bispecific Antibody INCA33890


Anti-PD-L1/PD-L2 Bispecific Antibody IMGS-001


Anti-CD30/CD3 Bispecific Antibody GEN3017


PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector IMNN-001


Follicular Helper T-Cell Lymphoma, Not Otherwise Specified


Recurrent Follicular Helper T-Cell Lymphoma


Refractory Follicular Helper T-Cell Lymphoma


Recurrent High Grade Endometrioid Adenocarcinoma


Ovarian Low Grade Endometrioid Adenocarcinoma


Ovarian High Grade Endometrioid Adenocarcinoma


Hyperpolarized Carbon 13 Alpha-ketoglutarate


Recurrent Primary Peritoneal Carcinosarcoma


MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ


ChAdOx1-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine ChAdOx1-PCAQ


Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma


Locally Advanced Differentiated Thyroid Gland Carcinoma


Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck


Follicular Lymphoma with Unusual Cytological Features


DPPG2-based Thermosensitive Liposomes Encapsulating Doxorubicin DPPG2-TSL-DOX


Modified Influenza Virus Expressing HPV16 E6/E7 FluBHPVE6E7


Anti-CA19-9 Antibody hu5B1/TCO Immunoconjugate


Acute Myeloid Leukemia with a Variant KMT2A Rearrangement


Copper 64 Cu-labeled Macrophage-targeted Nanoparticle


Anti-CD38 scFv/Anti-DOTA scFv Fusion Protein CD38-SADA


SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)


Pain of region of internal part of mouth


High Grade Squamous Intraepithelial Neoplasia


Well-differentiated neuroendocrine tumor grade 2 of lung


Yellow fever virus antigen only vaccine product


Neoplasm of cecum and/or colon and/or rectum


Lysosomal Acid Glucosylceramidase, Human


Multiple polyps of nasal cavity and/or nasal sinus


Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma


PLZ4-coated Paclitaxel-loaded Micelle Formulation


Cognitive impairment associated with schizophrenia


Myeloproliferative Chronic Myelomonocytic Leukemia


Engineered Toxin Body Targeting CTLA-4 MT-8421


Anti-PD-1/Anti-VEGF Bispecific Antibody JS207


Allogeneic Anti-B7-H3 CAR Gamma Delta T-cells QH104


Anti-CD19/Anti-CD3/Anti-CD28 Trispecific Antibody CC312


Anti-DLK-1 Antibody-drug Conjugate ADCT-701


EGFR/HER2 Mutant-selective Inhibitor STX-721


RXR-alpha Variant-targeting Agent NM6603


Anti-CD123/Kinesin Spindle Protein Inhibitor Antibody-drug Conjugate VIP943


Anti-dectin-2 Agonist Monoclonal Antibody BDC-3042


Anti-nectin-4 Antibody-drug Conjugate ADRX-0706


DNA Polymerase Theta Inhibitor GSK4524101


Anti-mutant Calreticulin Monoclonal Antibody INCA033989


Dual-activating Polyvalent STING Agonist ONM-501


Human Milk Oligosaccharides-based Formulation PBCLN-010


Autologous Anti-MSLN CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B694


Autologous dnTGF-BRII-armored Anti-GPC3 CAR T-cells AZD5851


GPRC5D/BCMA/CD3-targeting T-cell Engager IBI3003


Anti-HER3 Antibody-drug Conjugate SHR-A2009


Anti-PSMA/Anti-CD28 Bispecific Antibody JNJ-87189401


Adenosine A2A Receptor Antagonist JNJ-86974680


Anti-CD19/Anti-CD3/Anti-CD2 Trispecific Antibody PIT565


Engineered Interferon Alpha-2b Prodrug JZP898


Anti-CALRmut/Anti-CD3 Bispecific Antibody JNJ-88549968


Anti-CD123/TOP1i Antibody-drug Conjugate AZD9829


Anti-DLK-1/MMAE Antibody-drug Conjugate TORL-4-500


Anti-EpCAM/Anti-4-1BB Bispecific Antibody BNT314


Nanoparticle Encapsulated AChR Epitopes CNP-106


Oncolytic HSV-1 Expressing IL-2 and IL-12 KB707


Anti-TA-MUC1/DXd Antibody-drug Conjugate DS-3939a


Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR Gene Engineered T-lymphocytes NT-112


Anti-PD-L1/VEGF/TGF-beta Trispecific Antibody DR30206


Anti-B7-H4/Anti-4-1BB Bispecific Antibody ABL103


Anti-PD-1/Anti-PD-L1 Bispecific Antibody CTX-8371


Anti-TROP-2 Antibody-drug Conjugate HS-20105


Autologous CRISPR-edited Tumor Infiltrating Lymphocytes GT316


Autologous PSMA-inducible Anti-CA9 CAR T-cells AB-2100


Cisplatin Nano-engineered Intraoperative System PRV211


Autologous dnTGF-BRII-armored Anti-STEAP2 CAR T-cells AZD0754


Anti-CD47/CD20 Bispecific Antibody CC-96673


Anti-CLDN18.2/CD47 Bispecific Antibody AK132


Unresectable Penile Squamous Cell Carcinoma


Locally Advanced Extraskeletal Myxoid Chondrosarcoma


Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant


Advanced Fallopian Tube High Grade Serous Adenocarcinoma


Advanced Primary Peritoneal High Grade Serous Adenocarcinoma


Locally Advanced Olfactory Neuroblastoma


Refractory Juvenile Myelomonocytic Leukemia


Autologous Anti-EGFRvIII synNotch Receptor-induced Anti-EphA2/IL-13Ralpha2 CAR-T Cells


Autologous Total Tumor mRNA Loaded Liposome Vaccine


Stage III Cutaneous Merkel Cell Carcinoma AJCC v7


Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


Antenatal prevention of fetal injury of brain


SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705


Chronic kidney disease-associated pruritus


c-Met-targeting Tri-specific Natural Killer Cell Engager ABBV-303


Resectable Clear Cell Renal Cell Carcinoma


Anti-ROR1/Anti-CD3/Anti-HSA Trispecific Antibody NM32-2668


Anti-CEA/Anti-4-1BB Bispecific Antibody LM-24C5


Anti-PD-1/Anti-CD73 Bispecific Antibody AK131


PD-1 Targeted IL-2 Mutein Fusion Protein KY-0118


Anti-PSMA/STEAP1 Antibody-drug Conjugate ABBV-969


Anti-CD30 Antibody-drug Conjugate SGN-35C


Anti-nectin-4/MMAE Antibody-drug Conjugate CRB-701


Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 STX-001


Anti-HLA-G/CD3 Bispecific Antibody RO7515629


Anti-CLDN6/CD3 Bispecific Antibody XmAb541


Anti-CEA/Anti-DR5 Bispecific Antibody IBI3004


Anti-Siglec-10 Monoclonal Antibody ONC-841


Anti-EGFR/CD3 Bispecific Antibody SMET12


Locally Advanced Cervical Adenosquamous Carcinoma


Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia


Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia


Anti-EGFR/Anti-c-Met Monoclonal Antibody FPI-2053


Conditionally-activated Anti-EpCAM Antibody-drug Conjugate CX-2051


CD16-based ROR1-targeted NK Cell Engager PBA-0405


Pan-DDR DNA Decoy-cholesterol Conjugate VIO-01


Anti-B7-H4 Antibody Drug Conjugate BG-C9074


STAT3 Dual Phosphorylation Site Inhibitor YY201


Anti-CDH3/MMAE Antibody-drug Conjugate BC3195


Resectable Human Papillomavirus-Independent Mucosal Head and Neck Squamous Cell Carcinoma


Anti-TROP2 Antibody-drug Conjugate OBI-992


Recurrent Nasal Cavity Squamous Cell Carcinoma


Anti-PD-1/Anti-TIGIT Bispecific Antibody ZG005


Mutant-selective PI3K-alpha H1047R Inhibitor OKI-219


Anti-B7-H3 Antibody-drug Conjugate DB-1311


Recurrent Childhood Fibrolamellar Carcinoma


Refractory Childhood Fibrolamellar Carcinoma


Recurrent Childhood Myelodysplastic Syndrome


Refractory Childhood Myelodysplastic Syndrome


Anti-TAAs/Anti-CD3/Anti-CD28 Tetra-specific Antibody MDX2001


Liposomal Chk1 Inhibitor SMP-3124 SMP-3124LP


Childhood Acute Leukemia of Ambiguous Lineage


Anti-ILT2/Anti-ILT4 Bispecific Antibody PF-07826390


Anti-PD-1 Antibody-IL-15/IL-15Ra Fusion Protein IAP0971


Metastatic Childhood Malignant Solid Neoplasm


Alpha-clash Anti-IL-2 Antibody Fusion Protein LAT010


Anti-CD24/Anti-4-1BB Bispecific Monoclonal Antibody IBD0333


Anti-EpCAM/Anti-CD40 Bispecific Antibody KK2269


Anti-NaPi2b/Exatecan Antibody-drug Conjugate TUB-040


Anti-ULBP6 Monoclonal Antibody 23ME-01473


Anti-PD-1/IL-2Ra/IL-2 Fusion Protein REGN10597


Anti-nectin-4 Antibody-drug Conjugate LY4052031


Anti-CD20/Anti-CD3/Anti-CD8 Trispecific Antibody AZD5492


Refractory Childhood Non-Hodgkin Lymphoma


Anti-GPC3/Anti-4-1BB Bispecific Antibody BGB-B2033


Anti-B7-H3/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BGB-C354


Zirconium Zr 89 Anti-TAA Monoclonal Antibody BAY3630942


Anti-TAA Monoclonal Antibody-chelator Conjugate BAY3547922


Lipid Nanoparticle Encapsulating Beta-catenin siRNA ALN-BCAT


Autologous Tumor Membrane Vesicles Vaccine


Anti-FGFR2b/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BG-C137


Nonmetastatic Castration-Resistant Prostate Carcinoma


Metastatic Castration-Sensitive Prostate Carcinoma


Nonmetastatic Castration-Sensitive Prostate Carcinoma


Protease-activated Interferon Alpha-2b Prodrug CX-801


Locally Advanced Unresectable Malignant Solid Neoplasm


Lutetium Lu 177 Anti-PD-L1 Nanobody RAD204


Anal Non-Keratinizing Squamous Cell Carcinoma


Chronic otitis media with effusion (disorder)


CXC Chemokine Receptor 4 Antagonist [EPC]


recombinant interferon alpha 2b-like protein


pegylated granulocyte colony-stimulating factor


Methoxy polyethylene glycol-epoetin beta


HUMAN C1-ESTERASE INHIBITOR, RECOMBINANT


SBI_STAA9 Immunoglobulin-binding protein Sbi (sprot)


SBI_STAAE Immunoglobulin-binding protein Sbi (sprot)


SBI_STAA2 Immunoglobulin-binding protein Sbi (sprot)


SBI_STAA1 Immunoglobulin-binding protein Sbi (sprot)


SBI_STAAT Immunoglobulin-binding protein Sbi (sprot)


IBSA_ECOLI Small toxic protein IbsA (sprot)


F10A1_DROME Hsc70-interacting protein 1 (sprot)


DMBX1_CHICK Diencephalon/mesencephalon homeobox protein 1 (sprot)


RBMY_MOUSE RNA-binding motif protein, Y chromosome (sprot)


CNBP_CHICK CCHC-type zinc finger nucleic acid binding protein (sprot)


IMP1_SCHPO Mitochondrial inner membrane protease subunit 1 (sprot)


TRAC_HUMAN T cell receptor alpha chain constant (sprot)


TRAC_MOUSE T-cell receptor alpha chain constant (sprot)


HBB_CHICK Hemoglobin subunit beta (sprot)


PSMD8_DICDI Probable 26S proteasome non-ATPase regulatory subunit 8 (sprot)


VL1_HPV16 Major capsid protein L1 (sprot)


VE1_HPV16 Replication protein E1 (sprot)


LMP1_EBVB9 Latent membrane protein 1 (sprot)


ENV_HV1A2 Envelope glycoprotein gp160 (sprot)


ENV_HTLV2 Envelope glycoprotein gp63 (sprot)


OPSG_HUMAN Medium-wave-sensitive opsin 1 (sprot)


THRSP_RAT Thyroid hormone-inducible hepatic protein (sprot)


VTDB_RAT Vitamin D-binding protein (sprot)


GAG17_DROME Retrovirus-related Gag polyprotein from copia-like transposable element 17.6 (sprot)


ENV17_DROME Retrovirus-related Env polyprotein from copia-like transposable element 17.6 (sprot)


RECD_ECOLI RecBCD enzyme subunit RecD (sprot)


PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


PRP2_MOUSE Proline-rich protein 2 (sprot)


TSAD_ECOLI tRNA N6-adenosine threonylcarbamoyltransferase (sprot)


ENV_HV1C4 Envelope glycoprotein gp160 (sprot)


ERBB2_RAT Receptor tyrosine-protein kinase erbB-2 (sprot)


VP5_BTV10 Outer capsid protein VP5 (sprot)


GP_HANTV Envelopment polyprotein (sprot)


SPBP_RAT Prostatic spermine-binding protein (sprot)


SPA_STAAM Immunoglobulin G-binding protein A (sprot)


IHFB_ECOLI Integration host factor subunit beta (sprot)


HSCA_ECOLI Chaperone protein HscA (sprot)


IF3_ECOLI Translation initiation factor IF-3 (sprot)


RS5_ECOLI Small ribosomal subunit protein uS5 (sprot)


RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


ARAC_ECOLI Arabinose operon regulatory protein (sprot)


PFLA_ECOLI Pyruvate formate-lyase 1-activating enzyme (sprot)


ARCA_ECOLI Aerobic respiration control protein ArcA (sprot)


GARP_ECOLI Probable galactarate/D-glucarate transporter GarP (sprot)


YMCE_ECOLI Uncharacterized protein YmcE (sprot)


CYDA_ECOLI Cytochrome bd-I ubiquinol oxidase subunit 1 (sprot)


DCM_ECOLI DNA-cytosine methyltransferase (sprot)


CPDA_ECOLI 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA (sprot)


INGK_ECOLI Guanosine-inosine kinase (sprot)


MTNN_ECOLI 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (sprot)


GHOS_ECOLI Endoribonuclease antitoxin GhoS (sprot)


SUBI_ECOLI Sulfate-binding protein (sprot)


RPOH_ECOLI RNA polymerase sigma factor RpoH (sprot)


ENV1_DROME Retrovirus-related Env polyprotein from transposon gypsy (sprot)


GAGY_DROME Retrovirus-related Gag polyprotein from transposon gypsy (sprot)


SECA_ECOLI Protein translocase subunit SecA (sprot)


ENV2_MOUSE Retrovirus-related Env polyprotein from Fv-4 locus (sprot)


AADK_STAAU Aminoglycoside 6-adenylyltransferase (sprot)


GH_HCMVA Envelope glycoprotein H (sprot)


MSP1_PLAYO Merozoite surface protein 1 (sprot)


PERT_BORPE Pertactin autotransporter (sprot)


AROP_ECOLI Aromatic amino acid transport protein AroP (sprot)


PHNO_ECOLI Aminoalkylphosphonate N-acetyltransferase (sprot)


GM_HCMVA Envelope glycoprotein M (sprot)


DMSA_ECOLI Dimethyl sulfoxide reductase DmsA (sprot)


ID1_MOUSE DNA-binding protein inhibitor ID-1 (sprot)


tumor necrosis factor receptor superfamily member 9 isoform 1 (mouse)


GAG2_DROME Retrovirus-related Gag polyprotein from transposon 297 (sprot)


ENV2_DROME Retrovirus-related Env polyprotein from transposon 297 (sprot)


ENV_HV1JR Envelope glycoprotein gp160 (sprot)


GAGJ_DROME Nucleic-acid-binding protein from mobile element jockey (sprot)


WT1_MOUSE Wilms tumor protein homolog (sprot)


PAI1_MOUSE Plasminogen activator inhibitor 1 (sprot)


PTHR_MOUSE Parathyroid hormone-related protein (sprot)


SUIS_RAT Sucrase-isomaltase, intestinal (sprot)


COX2_CAEEL Cytochrome c oxidase subunit 2 (sprot)


GP_PUUMS Envelopment polyprotein (sprot)


PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


DMA_MOUSE Class II histocompatibility antigen, M alpha chain (sprot)


GLMM_ECOLI Phosphoglucosamine mutase (sprot)


SRY_RAT Sex-determining region Y protein (sprot)


RAD26_SCHPO DNA repair protein rad26 (sprot)


SPA_STAAU Immunoglobulin G-binding protein A (sprot)


CXOL_NPVAC Conotoxin-like peptide (sprot)


PPAL_SCHPO Low molecular weight phosphotyrosine protein phosphatase (sprot)


APA_MYCLE Alanine and proline-rich secreted protein Apa (sprot)


AGAL_MOUSE Alpha-galactosidase A (sprot)


FLII_ECOLI Flagellum-specific ATP synthase (sprot)


RHOX5_MOUSE Homeobox protein Rhox5 (sprot)


ST1A1_MOUSE Sulfotransferase 1A1 (sprot)


VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)


CNMD_DANRE Leukocyte cell-derived chemotaxin 1 (sprot)


DEF1_HUMAN Neutrophil defensin 1 (sprot)


ISPF_ECOLI 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (sprot)


TNR5_STRA5 Transposase from transposon Tn1545 (sprot)


MALG_ECOLI Maltose/maltodextrin transport system permease protein MalG (sprot)


CTG1B_HUMAN Cancer/testis antigen 1 (sprot)


SPA_STAAN Immunoglobulin G-binding protein A (sprot)


CSF1R_RAT Macrophage colony-stimulating factor 1 receptor (sprot)


PYC_MOUSE Pyruvate carboxylase, mitochondrial (sprot)


T2_MOUSE Octapeptide-repeat protein T2 (sprot)


VL1_HPV04 Major capsid protein L1 (sprot)


CD36_RAT Platelet glycoprotein 4 (sprot)


SG11B_HUMAN Sperm-associated antigen 11B (sprot)


hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


EPAG_HUMAN Early lymphoid activation gene protein (sprot)


TORI_ECOLI Response regulator inhibitor for tor operon (sprot)


SBI_STAA3 Immunoglobulin-binding protein Sbi (sprot)


MGRA_STAA8 HTH-type transcriptional regulator MgrA (sprot)


RL25_BRUA2 Large ribosomal subunit protein bL25 (sprot)


SBI_STAAB Immunoglobulin-binding protein Sbi (sprot)


AIFA_DICDI Apoptosis-inducing factor homolog A (sprot)


SBI_STAAC Immunoglobulin-binding protein Sbi (sprot)


DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


MCF2L_MOUSE Guanine nucleotide exchange factor DBS (sprot)


TFDP2_MOUSE Transcription factor Dp-2 (sprot)


TRI33_DANRE E3 ubiquitin-protein ligase TRIM33 (sprot)


SBI_STAAS Immunoglobulin-binding protein Sbi (sprot)


SBI_STAAR Immunoglobulin-binding protein Sbi (sprot)


SG11A_HUMAN Sperm-associated antigen 11A (sprot)


ADC_CHRVO Acetoacetate decarboxylase (sprot)


CEI_HUMAN Putative uncharacterized protein IRX2-DT (sprot)


LATH_HUMAN Putative BPIFA4P protein (sprot)


GAGO_DROME Retrovirus-related Gag polyprotein from transposon opus (sprot)


SBI_STAAW Immunoglobulin-binding protein Sbi (sprot)


TIP_RAT T-cell immunomodulatory protein (sprot)


CRLF2_RAT Cytokine receptor-like factor 2 (sprot)


EDAD_MOUSE Ectodysplasin-A receptor-associated adapter protein (sprot)


SBI_STAAM Immunoglobulin-binding protein Sbi (sprot)


GAGHB_DROME Retrovirus-related Gag polyprotein from transposon HMS-Beagle (sprot)


MAFB_DANRE Transcription factor MafB (sprot)


SPAT6_RAT Spermatogenesis-associated protein 6 (sprot)


SBI_STAAN Immunoglobulin-binding protein Sbi (sprot)


GATM_CHICK Glycine amidinotransferase, mitochondrial (sprot)


ASC_DANRE Apoptosis-associated speck-like protein containing a CARD (sprot)


DSLE_ARATH Zinc finger BED domain-containing protein DAYSLEEPER (sprot)


GLU2B_SCHPO Glucosidase 2 subunit beta (sprot)


NOC2L_MOUSE Nucleolar complex protein 2 homolog (sprot)


MTAD_THEMA 5-methylthioadenosine/S-adenosylhomocysteine deaminase (sprot)